Rational Design of Combination Enzyme Therapy for Celiac Sprue
- 1 June 2006
- journal article
- Published by Elsevier in Chemistry & Biology
- Vol. 13 (6) , 649-658
- https://doi.org/10.1016/j.chembiol.2006.04.009
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Heterologous Expression, Purification, Refolding, and Structural-Functional Characterization of EP-B2, a Self-Activating Barley Cysteine EndoproteaseChemistry & Biology, 2006
- Limited Efficiency of Prolyl-Endopeptidase in the Detoxification of Gliadin Peptides in Celiac DiseaseGastroenterology, 2005
- Fermentation, purification, formulation, and pharmacological evaluation of a prolyl endopeptidase from Myxococcus xanthus: Implications for Celiac Sprue therapyBiotechnology & Bioengineering, 2005
- Prolyl Endopeptidase-Mediated Destruction of T Cell Epitopes in Whole Gluten: Chemical and Immunological CharacterizationThe Journal of Pharmacology and Experimental Therapeutics, 2005
- Comparative biochemical analysis of three bacterial prolyl endopeptidases: implications for coeliac sprueBiochemical Journal, 2004
- Coordinated Induction by IL15 of a TCR-Independent NKG2D Signaling Pathway Converts CTL into Lymphokine-Activated Killer Cells in Celiac DiseaseImmunity, 2004
- A Direct Role for NKG2D/MICA Interaction in Villous Atrophy during Celiac DiseaseImmunity, 2004
- Gluten specific, HLA-DQ restricted T cells from coeliac mucosa produce cytokines with Th1 or Th0 profile dominated by interferon gamma.Gut, 1995
- Hormonal regulation, processing, and secretion of cysteine proteinases in barley aleurone layers.Plant Cell, 1990
- Ultrastructural changes suggestive of immune reactions in the jejunal mucosa of coeliac children following gluten challengeGut, 1973